Electronic health-records provider Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) said late last month that it would explore a sale of the company. Bloomberg is reporting this morning that private equity firms Blackstone Group LP (NYSE: BX), Carlyle Group LP (NASDAQ: CG) and privately held Silver Lake Management have all made first round bids on the company.
Allscripts has had a turbulent year. In April the company fired its chairman (and former CEO), the CFO resigned and three directors left — all on the same day. The impetus for the move came from a major shareholder, Healthcor Management, which placed three of its candidates on the board following the massacre.
Shares of Allscripts fell below $10 that day, and have managed to come back to north of $13 as of last Friday. At least one analyst put a target price of $15 on Allscripts the day it announced it would explore a sale of the company. Before the April disaster, the stock was trading at $16 and the 52-week high is over $21 a share. The trailing P/E is nearly 43, but the forward P/E is just over 14. The consensus target price is just $12.62.
The move to electronic health records under Obamacare makes Allscripts a valuable property. Just guessing here, but a buyout at $15 looks too cheap. And this company almost certainly will go to the highest bidder.
Shares of Allscripts closed at $13.33 on Friday, in a 52-week range of $8.84 to $21.66. Shares are up 5.8% in premarket trading this morning, at $14.10.
Paul Ausick
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
